Terms: = Head and neck cancer AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST AND Prognosis
76 results:
1. Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral cancer.
Reddi KK; Zhang W; Shahrabi-Farahani S; Anderson KM; Liu M; Kakhniashvili D; Wang X; Zhang YH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473906
[TBL] [Abstract] [Full Text] [Related]
2. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract] [Full Text] [Related]
3. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
[TBL] [Abstract] [Full Text] [Related]
4. head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.
Xu C; Xu H; Liu B
PeerJ; 2023; 11():e16364. PubMed ID: 38025757
[TBL] [Abstract] [Full Text] [Related]
5. The importance of sentinel lymph node diagnostic biopsy from the lateral neck compartment in the surgical treatment of papillary thyroid cance.
Arciniegas LM; Reken V; Nemergut S; Sabol M; Durdik S; Kralik R
Bratisl Lek Listy; 2023; 124(11):827-832. PubMed ID: 37874805
[TBL] [Abstract] [Full Text] [Related]
6. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract] [Full Text] [Related]
7. Carcinogenesis promotion in oral squamous cell carcinoma: KDM4A complex-mediated gene transcriptional suppression by LEF1.
Hou Y; Yu W; Wu G; Wang Z; Leng S; Dong M; Li N; Chen L
Cell Death Dis; 2023 Aug; 14(8):510. PubMed ID: 37553362
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma.
Qiu L; Tao A; Sun X; Liu F; Ge X; Li C
Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764
[TBL] [Abstract] [Full Text] [Related]
9. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
[TBL] [Abstract] [Full Text] [Related]
10. Influence of autoimmune thyroiditis on the prognosis of papillary thyroid carcinoma.
Grigerova M; Kasko M; Mojtova E; Takacsova E; Kralik R; Waczulikova I; Podoba J
Bratisl Lek Listy; 2022; 123(12):885-890. PubMed ID: 36342875
[TBL] [Abstract] [Full Text] [Related]
11. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
[No Abstract] [Full Text] [Related]
12. SESN1, negatively regulated by miR-377-3p, suppresses invasive growth of head and neck squamous cell carcinoma by interaction with SMAD3.
Zhang C; Ren L; Zhang H; Yang S; Deng M; He L; Cao R; Zhao C; Xia J
Hum Cell; 2022 Jul; 35(4):1100-1113. PubMed ID: 35622213
[TBL] [Abstract] [Full Text] [Related]
13. Design, synthesis and biological evaluation of new parbendazole derivatives for the treatment of HNSCC.
Liang D; Yu C; Ma Z; Hu M; Wang J; Dong X; Du L; Li M
Eur J Med Chem; 2022 Aug; 238():114450. PubMed ID: 35576703
[TBL] [Abstract] [Full Text] [Related]
14. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
15. Nimotuzumab shows an additive effect to inhibit cell growth of ALA-PDT treated oral cancer cells.
He X; Hu N; Yang S; Yang Z; Hu L; Wang X; Wen N
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102817. PubMed ID: 35331955
[TBL] [Abstract] [Full Text] [Related]
16. SNHG1/miR-145-5p/KLF5 Axis Participates in Regulating the Proliferation and Migration of Oral Squamous Cell cancer.
Xin H; Feng Z; Yao C
J Healthc Eng; 2022; 2022():2053271. PubMed ID: 35281530
[TBL] [Abstract] [Full Text] [Related]
17. miR-340-5p affects oral squamous cell carcinoma (OSCC) cells proliferation and invasion by targeting endoplasmic reticulum stress proteins.
Ou D; Wu Y; Zhang J; Liu J; Liu Z; Shao M; Guo X; Cui S
Eur J Pharmacol; 2022 Apr; 920():174820. PubMed ID: 35227681
[TBL] [Abstract] [Full Text] [Related]
18. miR-532-3p inhibits the progression of tongue squamous cell carcinoma by targeting podoplanin.
Liu ZY; Zhao CG
Chin Med J (Engl); 2021 Dec; 134(24):2999-3008. PubMed ID: 34939978
[TBL] [Abstract] [Full Text] [Related]
19. Characterization of cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
Feng J; Li Y; Wen N
Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
[TBL] [Abstract] [Full Text] [Related]
20. Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma.
Wang H; Yu T; Mao L
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3597-3609. PubMed ID: 34825969
[TBL] [Abstract] [Full Text] [Related]
[Next]
